Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 16 citing Arias: Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathologi.... (0.06 sec) 

[CITATION] Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to traumatic …


B Chanana, RV Azad, N Kumar - Eye, 2009 - nature.com
Jump to main content; Jump to navigation; nature.com homepage; Publications AZ index;
Browse by subject. My account; Submit manuscript; Register; Subscribe; RCOphth ...
Cited by 1 - Related articles - All 3 versions

Bevacizumab (Avastin) for the Treatment of Ocular Disease


JB Gunther, MM Altaweel - Survey of Ophthalmology, 2009 - Elsevier
The use of intravitreal bevacizumab (Avastin) has greatly expanded since its
introduction into ophthalmic care 3 years ago. A PubMed search on 1 August 2008
revealed 51 ocular disease processes that have been treated with ...
Cited by 2 - Related articles - All 23 versions

Comparison of Visual Outcome and Regression Pattern of Myopic Choroidal …


K Hayashi, K Ohno-Matsui, S Teramukai, N … - American Journal of Ophthalmology, 2009 - Elsevier
Forty-four eyes of 42 consecutive patients with myopic CNV treated with PDT, and
43 eyes of 43 consecutive patients with myopic CNV treated with IVB, were
evaluated. For control, 74 eyes of 71 consecutive patients with untreated ...
Cited by 1 - Related articles - All 24 versions

Avastin in myopic choroidal neovascularisation: is age the limit?

- prsjournal.com
D Wong, KKW Li - British Journal of Ophthalmology, 2008 - bjo.bmj.com
There are a growing number of publications supporting the use of Avastin
(bevacizumab) for choroidal neovascularisation (CNV) secondary to pathological
myopia (table 1).1 – 8 In this issue, Arias et al (see page 1035) ...
Cited by 1 - Related articles - All 4 versions

Anti-Vegf Drugs As the 2009 First-Line Therapy for Choroidal Neovascularization in …

- duanessolution.com
SY COHEN - Retina, 2009 - journals.lww.com
Choroidal neovascularization (CNV) is the com- mon cause of visual loss in
pathologic myopia. Among patients younger than 50 years, myopia ac- counted for
62% of cases of CNV.1 The natural his- tory of myopic subfoveal CNV has ...
Related articles - All 3 versions

Intravitreal Bevacizumab vs Sub-Tenon Triamcinolone Acetonide for Choroidal …


T Wakabayashi, Y Ikuno, F Gomi, T Hamasaki … - American Journal of Ophthalmology, 2009 - Elsevier
Fifty-four consecutive eyes of 53 patients with mCNV treated with either
sub-Tenon TA or intravitreal bevacizumab in an institutional setting were
included. Twenty eyes were treated with sub-Tenon TA and 34 eyes were ...
Related articles - All 10 versions

Vascular Endothelial Growth Factors and Their Inhibitors in Ocular Neovascular Disorders

- jovr.ir [PDF] 
M Homayouni - Journal of Ophthalmic & Vision Research, 2009 - jovr.ir
The introduction of pharmacotherapy has been one of the most important advances
in the management of retinal disorders. Age-related macular degeneration (AMD)
was once considered as an irrepressible disease leading to permanent ...
Related articles - View as HTML - All 7 versions

Intravitreal bevacizumab for CNV-complicated tilted disk syndrome


P Milani, A Pece, G Moretti, P Lino, A … - Graefe's Archive for Clinical and Experimental …, 2009 - Springer
Abstract Background Tilted disc syndrome is a congenital anomaly characterized
by an inferonasal “tilting” of the optic disc. We report three patients
affected by macular neovascularisation- complicated tilted disk syndrome ...
Related articles - All 2 versions

EFFECTS OF INTRAVITREAL BEVACIZUMAB IN REPEATED DOSES: An Experimental …


A SARI, U ADIGUZEL, N CANACANKATAN, N … - RETINA, 2009 - journals.lww.com
Pathologic angiogenesis is the main condition in many ocular diseases.
Age-related macular de- generation, diabetic retinopathy, retinopathy of pre-
maturity, and neovascular glaucoma are the main dis- eases involving ...
Related articles

[PDF] Bevacizumab (Avastin®) and Ranibizumab (Lucentis®) in the management of non-AMD …


W Horsley - netag.nhs.uk
• Choroidal neovascularisation can be due to numerous causes other than
age-related macular degeneration although these represent a minority of overall
cases compared with those due to AMD. ... • Within NHS North East about ...
Related articles - View as HTML


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google